United States

Analyst Research Report Snapshot


ALK-Abello AS






27 May 2015





Companies referenced:

Available for Immediate Download

ALK-Abello AS - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on ALK-Abello AS required for business and competitor intelligence needs - A study of the major internal and external factors affecting ALK-Abello AS in the form of a SWOT analysis - An in-depth view of the business model of ALK-Abello AS including a breakdown and examination of key business segments - Intelligence on ALK-Abello AS’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about ALK-Abello AS, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: ALK-Abello (or ‘the group’) is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, the US, Canada, China and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,855 people as on December 31, 2012. The group recorded revenues of DKK2,345 million ($405 million*) during the financial year ended December 2012 (FY2012), a decrease of 0.1% compared with FY2011. The operating profit of the group was DKK118 million ($20.4 million*) during FY2012, a decrease of 60.5% compared with FY2011. The net profit was DKK209 million ($36.1 million*) in FY2012, an increase of 4.5% over FY2011. *Calculated using a constant conversion rate of DKK1 = $0.1727 for the financial year ended December 31, 2012. Reasons to Purchase: - Gain understanding of ALK-Abello AS and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess ALK-Abello AS as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on ALK-Abello AS’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.